60 related articles for article (PubMed ID: 16497727)
1. Schwannomin inhibits tumorigenesis through direct interaction with the eukaryotic initiation factor subunit c (eIF3c).
Scoles DR; Yong WH; Qin Y; Wawrowsky K; Pulst SM
Hum Mol Genet; 2006 Apr; 15(7):1059-70. PubMed ID: 16497727
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of ras-mediated activator protein 1 activity and cell growth by merlin.
Kim H; Lim JY; Kim YH; Kim H; Park SH; Lee KH; Han H; Jeun SS; Lee JH; Rha HK
Mol Cells; 2002 Aug; 14(1):108-14. PubMed ID: 12243339
[TBL] [Abstract][Full Text] [Related]
3. Rac1-Mediated DNA Damage and Inflammation Promote Nf2 Tumorigenesis but Also Limit Cell-Cycle Progression.
Shi Y; Bollam SR; White SM; Laughlin SZ; Graham GT; Wadhwa M; Chen H; Nguyen C; Vitte J; Giovannini M; Toretsky J; Yi C
Dev Cell; 2016 Nov; 39(4):452-465. PubMed ID: 27818180
[TBL] [Abstract][Full Text] [Related]
4. Eukaryotic Initiation Factor 3C Can Affect the Proliferation and Invasion of Ovarian Cancer by Regulating the p53 Signalling Pathway.
Zhang J; Yang H; Wen F; Li Q; Luo H; Zi D
Recent Pat Anticancer Drug Discov; 2024 Apr; ():. PubMed ID: 38629365
[TBL] [Abstract][Full Text] [Related]
5. An innovative gene expression modulating strategy by converting nucleic acids into HNC therapeutics using carrier-free nanoparticles.
Liu H; Huang Y; Li Z; Han S; Liu T; Zhao Q
Front Immunol; 2023; 14():1343428. PubMed ID: 38274829
[TBL] [Abstract][Full Text] [Related]
6. eIF3c: a potential therapeutic target for cancer.
Emmanuel R; Weinstein S; Landesman-Milo D; Peer D
Cancer Lett; 2013 Aug; 336(1):158-66. PubMed ID: 23623922
[TBL] [Abstract][Full Text] [Related]
7. EIF3C Promotes Lung Cancer Tumorigenesis by Regulating the APP/HSPA1A/LMNB1 Axis.
Ding X; Hou L; Zhang H; Chen Z; Liu Z; Gong J; Tang Z; Hu R
Dis Markers; 2022; 2022():9464094. PubMed ID: 36157221
[TBL] [Abstract][Full Text] [Related]
8. Transcriptomic analyses of RNA-binding proteins reveal eIF3c promotes cell proliferation in hepatocellular carcinoma.
Li T; Li S; Chen D; Chen B; Yu T; Zhao F; Wang Q; Yao M; Huang S; Chen Z; He X
Cancer Sci; 2017 May; 108(5):877-885. PubMed ID: 28231410
[TBL] [Abstract][Full Text] [Related]
9. Eukaryotic initiation factor 3C silencing inhibits cell proliferation and promotes apoptosis in human glioma.
Hao J; Wang Z; Wang Y; Liang Z; Zhang X; Zhao Z; Jiao B
Oncol Rep; 2015 Jun; 33(6):2954-62. PubMed ID: 25823503
[TBL] [Abstract][Full Text] [Related]
10. Neurofibromatosis Type 2 (NF2) and the Implications for Vestibular Schwannoma and Meningioma Pathogenesis.
Bachir S; Shah S; Shapiro S; Koehler A; Mahammedi A; Samy RN; Zuccarello M; Schorry E; Sengupta S
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33445724
[TBL] [Abstract][Full Text] [Related]
11. Knockdown of EIF3C promotes human U-2OS cells apoptosis through increased CASP3/7 and Chk1/2 by upregulating SAPK/JNK.
Gao W; Hu Y; Zhang Z; Du G; Yin L; Yin Z
Onco Targets Ther; 2019; 12():1225-1235. PubMed ID: 30863090
[TBL] [Abstract][Full Text] [Related]
12. Eukaryotic translation initiation factor 3 subunit C is associated with acquired resistance to erlotinib in non-small cell lung cancer.
Shintani T; Higashisaka K; Maeda M; Hamada M; Tsuji R; Kurihara K; Kashiwagi Y; Sato A; Obana M; Yamamoto A; Kawasaki K; Lin Y; Kijima T; Kinehara Y; Miwa Y; Maeda S; Morii E; Kumanogoh A; Tsutsumi Y; Nagatomo I; Fujio Y
Oncotarget; 2018 Dec; 9(101):37520-37533. PubMed ID: 30680067
[TBL] [Abstract][Full Text] [Related]
13. EIF3C-enhanced exosome secretion promotes angiogenesis and tumorigenesis of human hepatocellular carcinoma.
Lee HY; Chen CK; Ho CM; Lee SS; Chang CY; Chen KJ; Jou YS
Oncotarget; 2018 Mar; 9(17):13193-13205. PubMed ID: 29568350
[TBL] [Abstract][Full Text] [Related]
14. Translation initiation factors and their relevance in cancer.
de la Parra C; Walters BA; Geter P; Schneider RJ
Curr Opin Genet Dev; 2018 Feb; 48():82-88. PubMed ID: 29153484
[TBL] [Abstract][Full Text] [Related]
15. eIF3: a factor for human health and disease.
Gomes-Duarte A; Lacerda R; Menezes J; Romão L
RNA Biol; 2018 Jan; 15(1):26-34. PubMed ID: 29099306
[TBL] [Abstract][Full Text] [Related]
16. Decreasing Eukaryotic Initiation Factor 3C (EIF3C) Suppresses Proliferation and Stimulates Apoptosis in Breast Cancer Cell Lines Through Mammalian Target of Rapamycin (mTOR) Pathway.
Zhao W; Li X; Wang J; Wang C; Jia Y; Yuan S; Huang Y; Shi Y; Tong Z
Med Sci Monit; 2017 Aug; 23():4182-4191. PubMed ID: 28854163
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of eIF4F components in meningiomas and suppression of meningioma cell growth by inhibiting translation initiation.
Oblinger JL; Burns SS; Huang J; Pan L; Ren Y; Shen R; Kinghorn AD; Welling DB; Chang LS
Exp Neurol; 2018 Jan; 299(Pt B):299-307. PubMed ID: 28610844
[TBL] [Abstract][Full Text] [Related]
18. Role of Eukaryotic Initiation Factors during Cellular Stress and Cancer Progression.
Sharma DK; Bressler K; Patel H; Balasingam N; Thakor N
J Nucleic Acids; 2016; 2016():8235121. PubMed ID: 28083147
[TBL] [Abstract][Full Text] [Related]
19. Components of the eIF4F complex are potential therapeutic targets for malignant peripheral nerve sheath tumors and vestibular schwannomas.
Oblinger JL; Burns SS; Akhmametyeva EM; Huang J; Pan L; Ren Y; Shen R; Miles-Markley B; Moberly AC; Kinghorn AD; Welling DB; Chang LS
Neuro Oncol; 2016 Sep; 18(9):1265-77. PubMed ID: 26951381
[TBL] [Abstract][Full Text] [Related]
20. Targeting translation initiation in breast cancer.
Akcakanat A; Hong DS; Meric-Bernstam F
Translation (Austin); 2014; 2(1):e28968. PubMed ID: 26779407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
